Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCPK - Delayed Quote USD

Zinzino AB (publ) (ZNZNF)

Compare
14.86
+0.95
+(6.83%)
At close: April 4 at 4:00:00 PM EDT
Loading Chart for ZNZNF
  • Previous Close 13.91
  • Open 14.50
  • Bid 13.09 x 39400
  • Ask 14.90 x 21500
  • Day's Range 13.91 - 14.50
  • 52 Week Range 3.80 - 15.60
  • Volume 1,820
  • Avg. Volume 3,094
  • Market Cap (intraday) 496.938M
  • Beta (5Y Monthly) 1.60
  • PE Ratio (TTM) 31.62
  • EPS (TTM) 0.47
  • Earnings Date --
  • Forward Dividend & Yield 0.29 (1.92%)
  • Ex-Dividend Date May 28, 2024
  • 1y Target Est --

Zinzino AB (publ), a direct sales company, provides dietary supplements and skincare products in Sweden and internationally. The company operates through two segments, Zinzino and Faun. It offers skincare products including cleansers, face creams, serums, and masks. The company provides coffee, coffee machines, accessories, and cups; immune, omega, and restored supplements; weight management products; gut health supplements; and home health test products. It also sells its products through online. The company was founded in 2005 and is based in Västra Frölunda, Sweden.

www.zinzino.com

242

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ZNZNF

View More

Performance Overview: ZNZNF

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

ZNZNF
105.53%
OMX Stockholm 30 Index (^OMX)
7.89%

1-Year Return

ZNZNF
551.18%
OMX Stockholm 30 Index (^OMX)
9.30%

3-Year Return

ZNZNF
999.76%
OMX Stockholm 30 Index (^OMX)
7.06%

5-Year Return

ZNZNF
1,355.97%
OMX Stockholm 30 Index (^OMX)
62.84%

Compare To: ZNZNF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ZNZNF

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    496.94M

  • Enterprise Value

    454.38M

  • Trailing P/E

    31.94

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.45

  • Price/Book (mrq)

    13.22

  • Enterprise Value/Revenue

    2.02

  • Enterprise Value/EBITDA

    17.76

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.66%

  • Return on Assets (ttm)

    13.43%

  • Return on Equity (ttm)

    52.11%

  • Revenue (ttm)

    2.21B

  • Net Income Avi to Common (ttm)

    169.17M

  • Diluted EPS (ttm)

    0.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    463.05M

  • Total Debt/Equity (mrq)

    11.93%

  • Levered Free Cash Flow (ttm)

    242M

Research Analysis: ZNZNF

View More

Company Insights: ZNZNF

Research Reports: ZNZNF

View More

People Also Watch